Adial Pharmaceuticals, Inc.
ADIL
$6.44
-$0.21-3.16%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -51.99M | -2.02M | -2.00M | -1.79M | -1.96M |
| Total Depreciation and Amortization | -100.00 | 100.00 | 100.00 | 100.00 | -100.00 |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 46.34M | 215.90K | 321.40K | 224.30K | 223.20K |
| Change in Net Operating Assets | -717.00K | 194.00K | 350.00K | -264.10K | -13.40K |
| Cash from Operations | -6.36M | -1.61M | -1.32M | -1.83M | -1.75M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 5.28M | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 0.00 | 0.00 | 0.00 |
| Cash from Investing | 5.28M | -- | 0.00 | 0.00 | 0.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 849.70K | 315.30K | 2.60M | 524.70K | 5.30M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 24.36M | -- | -- | -- | -- |
| Cash from Financing | 25.21M | 315.30K | 2.60M | 524.70K | 5.30M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 24.13M | -1.30M | 1.27M | -1.31M | 3.55M |